DrugNews: Pradaxa Study Reveals Stroke, Bleeding and Heart Attack Risks In Some Patients

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Pradaxa is a blood thinner approved by the FDA in 2010 as a stroke preventative for patients with atrial fibrillation.

New York, NY (PRWEB) September 17, 2013

The prescription drug resource center at DrugNews.net is announcing updated information on the site for patients taking the blood thinner Pradaxa. A newly-released study shows patients with mechanical heart valves may face higher risks of stroke, bleeding and heart attacks*.

DrugNews was created to improve the safety of patients taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Pradaxa is a blood thinner approved by the FDA in 2010 as a stroke preventative for patients with atrial fibrillation. Experts disagree, however, about its risks for internal bleeding. The FDA has advised Pradaxa is no more dangerous than traditional blood thinner warfarin**.

Others, like the Institute for Safe Medication Practices, have warned that patients may be nearly 5 times as likely to die from Pradaxa bleeding than from bleeding with warfarin***. A study this year from the Netherlands also suggests patients taking newer blood thinners like Pradaxa may be 55% more likely to suffer internal bleeding****.

Now, DrugNews has learned that researchers from Belgium reported a new study at the European Society of Cardiology which found patients with mechanical heart valves taking Pradaxa faced higher risks of stroke, valve blood clots, major bleeding and heart attacks than those taking warfarin*.

A growing number of patients have filed a Pradaxa lawsuit in the U.S. alleging internal bleeding, leading to the consolidation of cases in a special federal multidistrict litigation court. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. The latest court records show as many as 1,389 cases filed.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to visit DrugNews.net or speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugNews only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugNews.net today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*New England Journal of Medicine, 9/1/13; nejm.org/doi/full/10.1056/NEJMoa1300615?query=featured_home#t=article
**FDA, 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Institute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****Gastroenterology, July 2013; gastrojournal.org/article/S0016-5085(13)00290-4/fulltext


Contact